Uniplan Investment Counsel Inc. grew its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 76.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 333,220 shares of the company’s stock after purchasing an additional 144,903 shares during the period. Uniplan Investment Counsel Inc. owned approximately 1.62% of PetMed Express worth $11,046,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Pinebridge Investments L.P. increased its position in PetMed Express by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after purchasing an additional 27 shares during the period. Acrospire Investment Management LLC acquired a new position in PetMed Express during the 2nd quarter worth approximately $110,000. Sei Investments Co. increased its position in PetMed Express by 50,142.9% during the 3rd quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock worth $117,000 after purchasing an additional 3,510 shares during the period. Fred Alger Management Inc. purchased a new stake in shares of PetMed Express during the 2nd quarter worth approximately $162,000. Finally, Thompson Siegel & Walmsley LLC purchased a new stake in shares of PetMed Express during the 3rd quarter worth approximately $149,000. Institutional investors own 99.91% of the company’s stock.

In related news, Director Ronald J. Korn sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $35.57, for a total value of $35,570.00. Following the sale, the director now owns 73,833 shares of the company’s stock, valued at approximately $2,626,239.81. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.00% of the stock is currently owned by corporate insiders.

Several equities research analysts have recently commented on PETS shares. Craig Hallum reissued a “hold” rating and set a $40.00 price target (down previously from $43.00) on shares of PetMed Express in a research note on Monday, August 21st. They noted that the move was a valuation call. BidaskClub lowered PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Sidoti raised PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price target on the stock in a research note on Thursday, August 24th. ValuEngine raised PetMed Express from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Finally, Zacks Investment Research lowered PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $42.00.

Shares of PetMed Express, Inc. (PETS) opened at $42.16 on Thursday. PetMed Express, Inc. has a 52 week low of $19.21 and a 52 week high of $50.90. The stock has a market capitalization of $862.70, a P/E ratio of 28.10, a P/E/G ratio of 2.51 and a beta of 1.13.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The firm had revenue of $66.70 million for the quarter, compared to analyst estimates of $63.41 million. During the same quarter in the prior year, the company earned $0.24 EPS. PetMed Express’s revenue was up 9.7% on a year-over-year basis. analysts predict that PetMed Express, Inc. will post 1.67 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, November 17th. Investors of record on Monday, November 6th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date of this dividend was Friday, November 3rd. PetMed Express’s payout ratio is currently 53.69%.

WARNING: This piece was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://theolympiareport.com/2017/12/07/petmed-express-inc-pets-holdings-boosted-by-uniplan-investment-counsel-inc.html.

PetMed Express Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.